Novartis articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/06/19 16:51
2013/06/19 16:51
1h
EU fines Lundbeck and others 146 million euros fo...
EU fines Lundbeck and others 146 million euros for blocking rival drugs BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck (LUN.CO), a total of 146...
10
RELATED
Lundbeck European Union European Commission Joaquin Almunia Brussels
MENTIONED
2013/06/19 16:51
2013/06/19 16:51
Latest videos
2013/06/19 16:43
2013/06/19 16:43
1h
Valeant to buy Bausch + Lomb for $8.7B
Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's...
Lomb Holdings Inc. Bausch Valeant Pharmaceuticals Valeant Pharmaceuticals International Inc. Warburg Pincus
MENTIONED
2013/06/18 21:59
2013/06/18 21:59
20h
City Girl: Jenifer Rajkumar Sets Her Sights on Ne...
On Jan. 12, 2011, storm clouds were gathering and a majornor'easter was set to hit Long Island and Lower Manhattan with a vengeance.Hardly anyone was expected to attend the downtown Manhattan rally...
1
RELATED
2013/06/18 09:27
2013/06/18 09:27
1d
Expanding Switzerland’s ‘Health Valley’
The Campus Biotech owners are expected to soon move into the empty 40,000 square metre former Merck Serono building (Keystone) Backed by billionaires, a major new biotech research initiative in...
2013/06/17 21:40
2013/06/17 21:40
1d
CAMPANIA MEDICUL DE GARDĂ. Statul primește o lovi...
În forma actuală, taxa este făcută prost şi lasă loc multor căi de atac. Inclusiv Curtea Constituţională a semnalat o excepţie de neconstituţionalitate. Impozit pe un alt impozit În 12 iunie, Curtea...
3436
RELATED
2013/06/17 09:25
2013/06/17 09:25
2d
Nanotechnology Drug Delivery Market in the US 201...
Nanotechnology Drug Delivery Market In The Us Expected To Grow At A CAGR Of 84.79 Percent Over The Period 2012-2016 TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016,...
4
RELATED
Technavio Amgen Celgene Cephalon Elan Corp.
MENTIONED
2013/06/16 06:25
2013/06/16 06:25
3d
Incyte Drug Jakafi® (ruxolitinib) Improved Overal...
STOCKHOLM — Incyte Corporation (Nasdaq: INCY) today announced results from two ongoing clinical trials of Jakafi® (ruxolitinib), an oral JAK1 and JAK2 inhibitor that is FDA-approved for the treatment...
1
RELATED
2013/06/14 14:18
2013/06/14 14:18
5d
Why 3 Top Money Managers Say There Isn't A Divide...
Matthews Asia portfolio manager Jasper Madsen says you can find value and big dividends in the Far East, just not in Japan, where policymaker like Taro Aso (pictured above) are leading a new easy...
2013/06/14 10:42
2013/06/14 10:42
5d
UN GIGANT pe piața de medicamente a câștigat în i...
UN GIGANT pe piața de medicamente a câștigat în instanță anularea unei taxe clawback RECORD Compania farmaceutică Novartis, unul dintre primii cinci producători de medicamente la nivel mondial, a...
2013/06/14 07:17
2013/06/14 07:17
5d
Medivir Recruits a New Head of Commercial Operati...
Medivir AB (OMX: MVIR) (STO:MVIR-B) strengthens the executive management team by recruiting Henrik Krook as Executive VP Commercial. Henrik will be operationally and strategically responsible for the...
2013/06/14 02:17
2013/06/14 02:17
5d
Prize4Life et Knopp Neurosciences annoncent que l...
CAMBRIDGE (Massachusetts) et PITTSBURGH--(BUSINESS WIRE)--L’organisme Prize4Life et la société Knopp Neurosciences Inc. ont annoncé aujourd’hui la signature d’une entente en vertu de laquelle Knopp...
113
RELATED
Paris Toronto Vancouver Facebook Twitter
MENTIONED
2013/06/13 16:28
2013/06/13 16:28
6d
NEW YORK, June 13, 2013: Cancer Diagnostics Partn...
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare...
1
RELATED
2013/06/13 05:06
2013/06/13 05:06
6d
Cleaveland: Prescription drugs can break bank
When drug maker Novartis released its unique drug, Gleevec, in 2001, therapy cost each American patient $30,000 per year. Twelve years later, the cost has risen to $92,000 per year. Other companies...
Gleevec Novartis U.S. Food and Drug Administration
MENTIONED
2013/06/12 22:41
2013/06/12 22:41
6d
Jakafi® (ruxolitinib) Prescribing Information Upd...
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that the U.S. Food and Drug Administration (FDA) has updated prescribing information for Jakafi® (ruxolitinib) to...
U.S. Food and Drug Administration Wilmington Novartis Securities and Exchange Commission
MENTIONED
2013/06/12 18:43
2013/06/12 18:43
6d
Midday Stock Roundup
The S&P 500 slipped 0.29% to 1,621.37 in afternoon trading Wednesday. The Dow Jones industrial average was down 0.28% to 15,079.70, while the Nasdaq was off 0.43% to 3,422.02. The yield on a 10-year...
2013/06/12 17:32
2013/06/12 17:32
7d
NEW YORK, June 12, 2013: Skin Disease Treatment T...
INTRODUCTIONSTUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the...
2013/06/12 08:26
2013/06/12 08:26
7d
MADRID, June 12, 2013: GDS International Leads th...
MADRID, June 12, 2013 — /PRNewswire/ -- On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton...
Madrid Novartis European Union Sydney Miami
MENTIONED
2013/06/12 06:27
2013/06/12 06:27
7d
Ablynx to Present Data on Its Anti-IL-6R Nanobody...
GHENT, BELGIUM--(Marketwired - Jun 12, 2013) - Ablynx (EURONEXT BRUSSELS: ABLX) today announced that it will have an oral and poster presentation on its novel anti-IL-6R Nanobody, ALX-0061, at the...
2013/06/12 05:27
2013/06/12 05:27
7d
LEUVEN, Belgium, June 12, 2013: ThromboGenics' JE...
LEUVEN, Belgium, June 12, 2013 — /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines,...
2013/06/11 21:47
2013/06/11 21:47
7d
US stocks slip on Bank of Japan decision
US stocks fell, sending the Standard & Poor's 500 Index lower for a second day, after Bank of Japan Governor Haruhiko Kuroda said he sees no need to expand monetary stimulus immediately. JPMorgan...
20
RELATED
Bank of Japan NEW YORK US Federal Reserve Citigroup Inc. Sprint Nextel Corp.
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.